Maccura Biotechnology Co.Ltd (SHE:300463)
China
· Delayed Price · Currency is CNY 11.91
+0.31 (2.67%)
May 13, 2025, 9:45 AM CST
SHE:300463 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 22.3 | 118.76 | 312.62 | 708.18 | 956.6 | 793.92 | Upgrade
|
| Depreciation & Amortization | 336.58 | 336.58 | 311.89 | 270.2 | 236.2 | 205.22 | Upgrade
|
| Other Amortization | 2.7 | 2.7 | 5.93 | 4.21 | 3.15 | 3.51 | Upgrade
|
| Loss (Gain) From Sale of Assets | 6.73 | 6.73 | 4.17 | 4.12 | 4.05 | -0.94 | Upgrade
|
| Asset Writedown & Restructuring Costs | 135.22 | 135.22 | 9.54 | 22.46 | 26.01 | 5.31 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.88 | -2.88 | -1.52 | -3.04 | -0.39 | -0.99 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 38.27 | 36.26 | 7.76 | 20.36 | Upgrade
|
| Other Operating Activities | 159.35 | 12.2 | 80.63 | 45.15 | 126.85 | 121.2 | Upgrade
|
| Change in Accounts Receivable | 127.87 | 127.87 | 214.66 | -277.51 | 257.65 | -162.59 | Upgrade
|
| Change in Inventory | -0.8 | -0.8 | 11.09 | 15.21 | -19.23 | -240.89 | Upgrade
|
| Change in Accounts Payable | -77.74 | -77.74 | -51.46 | 47.91 | -45.96 | 369.94 | Upgrade
|
| Operating Cash Flow | 684.48 | 633.8 | 901.51 | 843.22 | 1,617 | 1,094 | Upgrade
|
| Operating Cash Flow Growth | -7.42% | -29.70% | 6.91% | -47.84% | 47.77% | 138.09% | Upgrade
|
| Capital Expenditures | -924.9 | -963.02 | -877.9 | -987.74 | -601.78 | -501.32 | Upgrade
|
| Sale of Property, Plant & Equipment | 21.07 | 20.81 | 18.18 | 20.25 | 1.95 | 3.8 | Upgrade
|
| Cash Acquisitions | - | - | - | -164.58 | - | - | Upgrade
|
| Divestitures | 5.64 | - | -8.69 | - | - | - | Upgrade
|
| Investment in Securities | 149.86 | 261.86 | 354.79 | -709.72 | -87.5 | -5 | Upgrade
|
| Other Investing Activities | 11.85 | 2.88 | 10.58 | 11.96 | 0.52 | - | Upgrade
|
| Investing Cash Flow | -736.49 | -677.47 | -503.04 | -1,830 | -686.81 | -502.52 | Upgrade
|
| Long-Term Debt Issued | - | 685.9 | 608.75 | 605.13 | 762.97 | 1,057 | Upgrade
|
| Long-Term Debt Repaid | - | -613.03 | -513.84 | -914.44 | -1,115 | -1,240 | Upgrade
|
| Net Debt Issued (Repaid) | 212.35 | 72.87 | 94.91 | -309.31 | -352.18 | -183.11 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,558 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -175.43 | -6.49 | Upgrade
|
| Common Dividends Paid | -130.09 | -115.19 | -244.64 | -318.44 | -296.6 | -105.41 | Upgrade
|
| Other Financing Activities | -61.02 | -84.46 | -3.02 | -0.62 | -70.49 | -138.36 | Upgrade
|
| Financing Cash Flow | 21.24 | -126.78 | -152.75 | 930.05 | -894.69 | -433.37 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.1 | 0.19 | 1.35 | 5.19 | -2.15 | -5.39 | Upgrade
|
| Net Cash Flow | -30.66 | -170.26 | 247.07 | -51.38 | 33.02 | 152.76 | Upgrade
|
| Free Cash Flow | -240.42 | -329.22 | 23.61 | -144.52 | 1,015 | 592.73 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 71.23% | - | Upgrade
|
| Free Cash Flow Margin | -9.84% | -12.92% | 0.81% | -4.00% | 25.50% | 16.00% | Upgrade
|
| Free Cash Flow Per Share | -0.39 | -0.54 | 0.04 | -0.24 | 1.82 | 1.06 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 68.19 | Upgrade
|
| Cash Income Tax Paid | 160.83 | 160.83 | 137.38 | 311.46 | 412.06 | 319.15 | Upgrade
|
| Levered Free Cash Flow | -66.31 | -183.58 | -54.49 | -410.11 | 404.7 | 254.2 | Upgrade
|
| Unlevered Free Cash Flow | -66.31 | -183.58 | -33.53 | -388.2 | 441.75 | 296.81 | Upgrade
|
| Change in Net Working Capital | -399.29 | -265.67 | -319.3 | 184.58 | -27.86 | 58.53 | Upgrade
|
Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.